The IBD process triggers the release of inflammatory factors via various signaling pathways among which are the Toll-like receptor pathway, MyD88, mitogen-activated protein kinase (MAPK) pathway, and NF-κB pathway (Xiong et al., 2022; Zhu et al., 2023). This evidence concerns the gene NFKB1 and inflammatory bowel disease.